Table 3 Regression analysis of cardiovascular endurance
From: Abnormal body composition, cardiovascular endurance, and muscle strength in pediatric SLE
Variable | Coefficient | P-value |
|---|---|---|
Age, years | 0.5 | 0.5 |
African American Race | −9.7 | 0.06 |
Years of SLE | 0.2 | 0.06 |
Physically Active | 7.7 | 0.2 |
Malar rash | −5.6 | 0.2 |
Kidney Disease | −10 | 0.007 |
dsDNA positive, | −11.6 | 0.1 |
Ro/La positive | −1.5 | 0.8 |
Smith positive | −9.9 | 0.02 |
Low C3/C4 | −10.4 | 0.04 |
Prednisone | −9.1 | 0.02 |
Methotrexate | −1.5 | 0.8 |
Mycophenolate mofetil | −6.5 | 0.1 |
Body Fat >30 % | −5.4 | 0.3 |
Muscle mass >60 % | 9.7 | 0.01 |